Patent · US Expired

5-Iminodoxorubicin

US4353894A · kind A · utility

3Cited by
2References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 2, 1981
Grant dateOct 12, 1982
Priority date—
Expiry dateNov 2, 2001

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H15/252
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

5-Iminodoxorubicin and its pharmaceutically acceptable acid addition salts having good antitumor activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.